Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
11/27/1997 | CA2256305A1 Specific inhibitors of dna methyltransferase enzyme |
11/27/1997 | CA2256302A1 Endoglucanases |
11/27/1997 | CA2256109A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
11/27/1997 | CA2256039A1 Immortal avian cells |
11/27/1997 | CA2256038A1 Immortalized avian cell lines |
11/27/1997 | CA2255906A1 Human interleukin-1j and antagonists thereof |
11/27/1997 | CA2255888A1 Modulating the activity of hormones or their receptors - peptides, antibodies, vaccines and uses thereof |
11/27/1997 | CA2255760A1 Identification of target bacteria by fluorescence detection of primer directed amplification products |
11/27/1997 | CA2255723A1 Methods for identifying a mutation in a gene of interest |
11/27/1997 | CA2255712A1 Characterization and use of an isolated uridine diphospho-glucuronosyltransferase |
11/27/1997 | CA2255579A1 Mitogen-activated protein kinase p38-2 and methods of use therefor |
11/27/1997 | CA2255572A1 Use of chemokine antagonist molecules for their antiviral activity, particularly against an hiv type retrovirus |
11/27/1997 | CA2255541A1 Synthetic glucagon binding proteins |
11/27/1997 | CA2255538A1 Nucleic acid molecules coding soluble maize starch synthases |
11/27/1997 | CA2254843A1 Human b-cell antigens, related reagents |
11/27/1997 | CA2254083A1 Polycystic kidney disease gene |
11/27/1997 | CA2254065A1 Nucleoside derivatives with photoliable protective groups |
11/27/1997 | CA2253874A1 Viral particles which are masked or unmasked with respect to a cell receptor |
11/27/1997 | CA2253541A1 Human phospholipase inhibitor |
11/27/1997 | CA2253431A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
11/27/1997 | CA2227171A1 Icea gene and related methods |
11/26/1997 | EP0808907A2 Compositions and methods for the detection of mycobacterium kansasii |
11/26/1997 | EP0808905A2 Adenoviral vector for the transfer of human genes in vivo |
11/26/1997 | EP0808904A2 Interleukin-1 beta converting enzyme like apoptotic protease-6 |
11/26/1997 | EP0808903A2 Recombinantly produced lysophospholipase from aspergillus |
11/26/1997 | EP0808902A2 Novel genes encoding antiviral proteins of Phytolacca insularis Nakai and recombinant microorganisms expressing the same proteins |
11/26/1997 | EP0808901A2 Pharmaceutical preparation with factor VIII procoagulant activity and vWF-binding activity |
11/26/1997 | EP0808900A2 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
11/26/1997 | EP0808899A2 Human marco scavenger receptor (HMarcoSR) |
11/26/1997 | EP0808898A1 Reagent and method for inhibition of N-ras expression |
11/26/1997 | EP0808897A1 New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
11/26/1997 | EP0808844A2 Antisense oligonucleotides complementary to the primary transcript of the human c-fes protooncogene and their use, combined with a differentiation inducer to cause apoptosis of leukemic blast cells |
11/26/1997 | EP0808374A1 Method for modulating processes mediated by farnesoid activated receptors |
11/26/1997 | EP0808372A1 Agrobacterium mediated transformation of eucalyptus |
11/26/1997 | EP0808371A1 Expression of sucrose phosphorylase in plants |
11/26/1997 | EP0808370A1 Stress-tolerant plants and methods of producing the same |
11/26/1997 | EP0808369A1 GnRH-LEUKOTOXIN CHIMERAS |
11/26/1997 | EP0808368A1 Dna sequence encoding plant 2-acyltransferase |
11/26/1997 | EP0808367A1 Mucosal vascular addressins and uses thereof |
11/26/1997 | EP0808366A1 IDENTIFICATION OF DEC, (DENTRITIC AND EPITHELIAL CELLS, 205 kDa), A RECEPTOR WITH C-TYPE LECTIN DOMAINS, NUCLEIC ACIDS ENCODING DEC, AND USES THEREOF |
11/26/1997 | EP0808365A1 Human interleukin-1 receptor accessory protein |
11/26/1997 | EP0808364A1 Human pancreatic cell lines: developments and uses |
11/26/1997 | EP0808363A1 A method of designing alpha-amylase mutants with predetermined properties |
11/26/1997 | EP0808362A1 Herpes simplex virus mutants |
11/26/1997 | EP0808351A2 Cytoplasmic antiproteinase-2 and cytoplasmic antiproteinase-3 and coding sequences |
11/26/1997 | EP0808324A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
11/26/1997 | EP0808323A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |
11/26/1997 | EP0808322A1 RIBOZYMES WITH OPTIMIZED HYBRIDIZING ARMS, STEMS, AND LOOPS, tRNA EMBEDDED RIBOZYMES AND COMPOSITIONS THEREOF |
11/26/1997 | EP0808321A1 InK4c-p18 AND InK4D-p19, INHIBITORS OF CYCLIN-DEPEDENT KINASES CDK4 AND CDK6, AND USES THEREOF |
11/26/1997 | EP0808320A1 Novel chain terminators, the use thereof for nucleic acid sequencing and synthesis and a method of their preparation |
11/26/1997 | EP0808169A1 Programmed cell death genes and proteins |
11/26/1997 | EP0808104A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS |
11/26/1997 | EP0763113A4 Genetic sequences conferring disease resistance in plants and uses therefor |
11/26/1997 | EP0755451A4 Materials and methods for management of hyperacute rejection in human xenotransplantation |
11/26/1997 | EP0746610A4 Mammalian cloning by embryonic stem cell (esc) nuclear transplantation and esc |
11/26/1997 | EP0691977B1 Oligonucleotides with amide linkages replacing phosphodiester linkages |
11/26/1997 | EP0687307A4 Inhibition of tax-mediated increase in dna binding |
11/26/1997 | EP0662130B1 A method of producing hepatocyte growth factor and a cell line |
11/26/1997 | EP0548095B1 Pharmaceutical compositions containing superoxide dismutase from bacillus stearothermophilus and bacillus caldotenax |
11/26/1997 | EP0542863B1 Expression of recombinant polypeptides with improved purification |
11/26/1997 | EP0482176B1 Monoclonal antibodies specific for toxin b of clostridium difficile |
11/26/1997 | EP0466816B1 Method for enhancing transmembrane transport of exogenous molecules |
11/26/1997 | CN1166183A Calcium free subtilisin mutants |
11/26/1997 | CN1166182A D-pantolactone hydrolase and gene encoding the same |
11/26/1997 | CN1165862A Amplifying and detecting target nucleic acids using post amplification incubation step |
11/26/1997 | CN1165861A Chinese G-type hepatitis virus C gene sequence and its use |
11/26/1997 | CN1165859A Enhanced accummulation of trehalose in plants |
11/26/1997 | CN1165858A Construction method of muta lead mycillin of clone with salmon thyrocalcitonin gene |
11/26/1997 | CN1036532C Process for preparing non-glycosylated recombining human IL2 in reduced form |
11/25/1997 | US5691461 Oligonucleotides inhibiting candida germ tube formation |
11/25/1997 | US5691454 APC antibodies |
11/25/1997 | US5691449 Respiratory syncytial virus vaccines |
11/25/1997 | US5691448 Glutamic acid decarboxylase protein for autoantibody binding to epitopes |
11/25/1997 | US5691447 GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
11/25/1997 | US5691317 Antisense oligonucleotides of human regulatory subunit RI-alpha of cAMP dependent protein kinases for the treatment of cancer |
11/25/1997 | US5691308 Polypeptide insecticide |
11/25/1997 | US5691306 Protein secretion |
11/25/1997 | US5691199 DNA encoding biocidal proteins |
11/25/1997 | US5691197 Isolated DNA sequence for a novel macrophage receptor with a collagenous domain |
11/25/1997 | US5691196 Recombinant nucleic acid containing a response element |
11/25/1997 | US5691190 Phaffia rhodozyma mutants, process for producing β-carotene and use of β-carotene rich biomass |
11/25/1997 | US5691189 Saccharomyces cerevisiae expressing M2 protein of influenza A virus |
11/25/1997 | US5691188 Genetic engineering |
11/25/1997 | US5691187 Anti-fungal agents and methods of identifying and using the same |
11/25/1997 | US5691186 Filariid cysteine protease genes |
11/25/1997 | US5691185 Lactic acid bacterial suppressor mutants and their use as selective markers and as means of containment in lactic acid bacteria |
11/25/1997 | US5691183 CD4+ T-lymphoctye proteases and genes encoding said proteases |
11/25/1997 | US5691179 Polynucleotide |
11/25/1997 | US5691177 Lymphocytes and genetic vectors for treatment of cancer or autoimmune diseases |
11/25/1997 | US5691176 Recombinant adeno-associated virus vector packaging cells and methods for use |
11/25/1997 | US5691175 Immortalized human fetal osteoblastic cells |
11/25/1997 | US5691171 Culture of escherichia with a gene from bacillus encoding phenol hydroxylase and dna sequences |
11/25/1997 | US5691169 Process for preparing a desired protein |
11/25/1997 | US5691168 DNA sequences encoding AlaGlu-IGF-1 and vectors and microorganisms comprising said sequences |
11/25/1997 | US5691167 DNA encoding allergenic proteins and peptides from Johnson grass pollen |
11/25/1997 | US5691166 Gene expression for genetic engineering using dna for plasmids |
11/25/1997 | US5691163 Cells with altered betaine catabolism and their use in producing metabolites or enzymes |
11/25/1997 | US5691162 Metalloprotease having increased activity |
11/25/1997 | US5691161 Nucleic acid compounds |
11/25/1997 | US5691157 Method for detecting a mammal's prior exposure to radiation or radiomimetic chemicals |